Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

Combining Zephyr and Spiration valve therapy benefited patients with COPD and advanced pulmonary emphysema while imparting a ...

Sponsor:  Consultancy Media for Sanofi and Regeneron In the state of Ohio alone, more than 800,000 people are living with COPD. It’s a chronic lung disease that limits air flow and ...

The surprise finding hints that anti–acid reflux therapy may provide benefit in COPD, possibly by reducing micro-aspirations, ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

2024年9月16日，由首都医科大学附属北京朝阳医院（以下简称朝阳医院呼吸与危重症医学科/北京市呼吸疾病研究所作为牵头单位，联合国内30家医院协作完成的多中心研究“Effect of High-Intensity vs Low-Intensity ...

继 7 月份获得欧洲监管机构批准赛诺菲和再生元的 Dupixent，用于治疗血液嗜酸性粒细胞升高且未得到控制的慢性阻塞性肺病（COPD）成人患者后。 中国国家药品监督管理局和 FDA 于近日批准 Dupixent（dupilumab / 度普利尤单抗 ...